Study to understand the effect of the mushroom-based soup mix for diabetes control in pre diabetic patients.
Not Applicable
- Conditions
- Health Condition 1: E11- Type 2 diabetes mellitus
- Registration Number
- CTRI/2024/04/065449
- Lead Sponsor
- Metflux Research Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of all genders, age group 18 to 60 years
2. Patients with HbA1c level between 5.8% and 6.4%.
3. Participants must be drug-naive diabetics (i.e., those who have not previously received any pharmacological treatment for diabetes) or diabetics who are not currently on any oral hypoglycemic agents (OHA).
4. Patients who are willing to not take the medication during the study period.
Exclusion Criteria
1. Patients with HbA1C less than 5.8% and more than 6.4%
2. Patients who are prescribed medications for sugar control
3. Pregnant and lactating women, patients with untreated thyroid disease
4. Patients with any use of or has a history of drug and/or alcohol abuse
5. Patients with psychiatric or mental disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the changes in HbA1c and lipid level of the patients post consumption of mushroom oyster soup. To evaluate the changes in lifestyle behavior of the patients post consumption of mushroom oyster soup.Timepoint: on Day 45 and on day 90
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI